';
Policy Areas

The following updates have been released regarding the Personal Care Home (PCH) and Assisted Living Residence (ALR) ListServs:

  • As of 6/22/2022, the PCH and ALR ListServ(s) have been merged. This action was taken in order to maintain consistency and streamline the flow of information, as well as to decrease duplicate emails in your inbox.
  • As of 6/22/2022, all provider emails will be subscribed to the ListServ. Please maintain your subscription and ensure that your email servers are set up to accept emails from [email protected], as well as emails from PA.GOV addresses.
  • Archives from the previous ListServ(s) can be accessed by visiting:
  • If we are unable to maintain email contact, you will undoubtedly miss information that is crucial to the operation of your facility. Any changes to facility administrator or email contact information should be reported to your regional office or to PWARL Headquarters.
  • Anyone who wishes to subscribe to the ListServ may do so by visiting OLTL Adult Residential Licensing ListServ.

Questions about this information should be addressed by calling the Operator Support Hotline at 866-503-3926 or by email.

**This communication was originally sent on 6/9/2022, but due to technical issues, the actions outlined below were not completed until 6/21/2022.**

assistance, support, guidance - business concept words in color hexagons over blue background, flat design

The Department of Human Services (DHS) is pleased to announce new provider enrollment portal enhancements designed to improve a provider’s enrollment experience. Providers will enter the enrollment portal from PROMISe™ using their existing registered login criteria. Upon successful login, providers will have access to these new enhancements:

  1. Applications for adding additional service locations, revalidations, and reactivations will prepopulate parts of your application;
  2. After logging into the portal, existing providers will be able to submit change requests to update their provider file without the need to complete a full application; and
  3. Proof of provider enrollment status with PA Medicaid is available to view and print.

See the PROMISe Quick Tips update for more information. If you do not have an existing login, please select “Register Now” in the Provider Login box and complete the process options. Additional enhancements are planned and will be communicated through future banner alerts and quick tips.

If you have further questions, please contact RCPA Policy Director Jim Sharp.

The Pennsylvania Department of State (DOS) has reversed course and extended its waiver allowing for an initial prescription of buprenorphine without an in-person physical exam. DOS had announced previously that the waiver would expire on June 30, 2022; however, DOS’s waiver will now continue until the last day of the federal public health emergency declaration, unless the exemptions are ended sooner by the Substance Abuse and Mental Health Services Administration (SAMHSA) or the US Drug Enforcement Administration (DEA).

On Sept. 4, 2020, DOS issued a waiver suspending the State Board of Medicine’s regulation at 49 Pa. Code § 16.92(b)(1), which requires an initial physical examination of a patient prior to prescribing buprenorphine for the treatment of opioid use disorder. This waiver was sought specifically to complement the Department of Drug and Alcohol Programs’ (DDAP) suspension of 28 Pa. Code § 715.9(a)(4) and “relates to Federal exemptions granted under the Federal public health emergency (PHE) declaration,” specifically the exemptions granted by the federal Substance Abuse and Mental Health Services Administration (SAMHSA) and the U.S. Drug Enforcement Agency (DEA).

Therefore, in accordance with section 2102-F(a.3) of the Pennsylvania Administrative Code of 1929 (amended by Act 14 of 2022), the Department of State’s waiver will continue until the last day of the federal public health emergency declaration, unless the exemptions are ended sooner by SAMHSA or the DEA. This waiver will not expire on June 30, 2022. More information about the federal public health emergency can be found here.

It is important to note that, to be considered within the acceptable and prevailing standard of care, the physician/prescriber must be following the applicable SAMHSA/DEA guidelines.

Pennsylvania has not received notification that the PHE will be terminated on July 15. The commonwealth expects the PHE to be extended again. If this occurs, this waiver and others tied to or related to the PHE will be extended until mid-October 2022.

Additional information: